Register for the FDA, NIAAA, AASLD Workshop: Clinical Trial Design and Endpoints for Alcoholic Hepatitis and other Alcohol-Associated Liver Diseases, March 26-27

The purpose of thisworkshop is to address challenges related to clinical trial designs and drug development in Alcoholic Associated Liver Disease (AALD) and Alcoholic Hepatitis (AH) including populations to study, endpoints, and diagnostic criteria.  For additional details visit https://niaaa.nih.gov/alcoholic-hepatitis-workshop-fda-niaaa-aasld  

Source: NIAAA News - February 21, 2018 Category: Addiction Authors: groa Source Type: news